Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
The Annals of Pharmacotherapy|July 9, 2009
Safety and clinical outcomes when utilizing high-dose (> or =8 mg/kg) daptomycin therapyPamela A Moise, Ellie Hershberger, Maria I Amodio-Groton, et al.
Surgery|July 25, 2009
Daptomycin for the treatment of surgical site infectionsRonald S Chamberlain, Darren L Culshaw, Brian J Donovan, et al.
The Annals of Pharmacotherapy|January 24, 2008
Clinical experience with daptomycin for the treatment of patients with documented gram-positive septic arthritisGraeme N Forrest, Brian J Donovan, Kenneth C Lamp, et al.
International Journal of Antimicrobial Agents|February 12, 2013
Safety of daptomycin in patients completing more than 14 days of therapy: results from the Cubicin® Outcomes Registry and experienceShruta Rege, John Mohr, Kenneth C Lamp, et al.
The American Journal of Medicine|October 16, 2007
Daptomycin in the treatment of bacteremiaGeorge Sakoulas, Yoav Golan, Kenneth C Lamp, et al.
Clinical Therapeutics|October 22, 2009
Clinical outcomes of patients receiving daptomycin for the treatment of Staphylococcus aureus infections and assessment of clinical factors for daptomycin failure: a retrospective cohort study utilizing the Cubicin Outcomes Registry and ExperienceGeorge Sakoulas, Jack Brown, Kenneth C Lamp, et al.
Clinical Orthopaedics and Related Research|June 6, 2007
Clinical experience with daptomycin treatment of foot or ankle osteomyelitis: a preliminary studyPaul D Holtom, Charalampos G Zalavras, Kenneth C Lamp, et al.
The Annals of Pharmacotherapy|March 29, 2012
Daptomycin experience in critical care patients: results from a registryJack E Brown, Cory Fominaya, Keith J Christensen, et al.
Pharmacotherapy|September 20, 2011
Safety of daptomycin in patients receiving hemodialysisBruce A Mueller, Jason A Crompton, Brian J Donovan, et al.
The American Journal of Geriatric Pharmacotherapy|November 25, 2004
Clinical efficacy, tolerability, and cost savings associated with the use of open-label metronidazole plus ceftriaxone once daily compared with ticarcillin/clavulanate every 6 hours as empiric treatment for diabetic lower-extremity infections in older malesPatrick G Clay, Maqual R Graham, Cameron C Lindsey, et al.
Pageof 4